Wegovy recall (Novo Nordisk Inc.)
DrugClass IIOngoing
Summary: Novo Nordisk Inc. is recalling Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14. Reason: Presence of Particulate Matter: Hair was found in a prefilled syringe.
What is being recalled
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Why
Presence of Particulate Matter: Hair was found in a prefilled syringe
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
Nationwide within the United States.
How to tell if yours is affected
Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0244-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | December 19, 2025 |
| Reported | January 7, 2026 |
| Company | Novo Nordisk Inc. |
| Company location | Plainsboro, NJ, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | N/A |
More recalls from Novo Nordisk Inc. · all drug recalls · recalls from December 2025